Salmon S E, Smith B A
J Clin Invest. 1970 Jun;49(6):1114-21. doi: 10.1172/JCI106327.
Studies of synthesis of IgG paraproteins were performed in 10 patients who had IgG myeloma in order to quantitate cellular immunosynthetic functions and derive estimates of the number of tumor cells present in such patients. Serial in vitro studies demonstrated constancy in the cellular rate of IgG paraprotein secretion for up to 8 months. Average molecular synthesis rates in different patients ranged from 12,500 to 85,000 molecules of IgG per minute per myeloma cell. Estimated total body tumor cell number ranged from 0.5 x 10(12) to 3.1 x 10(12) myeloma cells, and could be correlated with the degree of skeletal damage observed on roentgenograms (P = <0.01). Serial measurements of tumor cell number may prove useful in characterizing the growth rate and natural history of multiple myeloma. Myeloma is the first metastatic human malignancy in which quantitative measurements of the body's burden of malignant cells have been obtained.
对10例患有IgG骨髓瘤的患者进行了IgG副蛋白合成研究,以定量细胞免疫合成功能,并估算此类患者体内存在的肿瘤细胞数量。连续的体外研究表明,IgG副蛋白分泌的细胞速率在长达8个月的时间内保持恒定。不同患者的平均分子合成速率为每个骨髓瘤细胞每分钟12,500至85,000个IgG分子。估计全身肿瘤细胞数量在0.5×10¹²至3.1×10¹²个骨髓瘤细胞之间,并且与X线片上观察到的骨骼损害程度相关(P = <0.01)。肿瘤细胞数量的连续测量可能有助于表征多发性骨髓瘤的生长速率和自然病程。骨髓瘤是首个已获得体内恶性细胞负荷定量测量值的人类转移性恶性肿瘤。